Spesolimab

Therapeutic indications

Spesolimab is indicated for:

Generalised pustular psoriasis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Spesolimab is indicated for the treatment of generalised pustular psoriasis (GPP) flares in adults and adolescents from 12 years of age as monotherapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

900 mg once

For patients weighing ≥30 and <40 kg 450 mg once and for patients weighing ≥40 kg 900 mg once

Contraindications

Spesolimab is contraindicated in the following cases:

Pregnancy

Clinically important active infections

Infectious disease

Live vaccines

Live organism vaccines

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.